Massachusetts Institute of Technology: Better Way to Encapsulate Islet Cells for Diabetes Treatment
June 25, 2019
June 25, 2019
CAMBRIDGE, Massachusetts, June 25 [TNSmedicalresearch] -- The Massachusetts Institute of Technology issued the following news:
* * *
- Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
* * *
When medical devices are implanted in the body, the immune system often attacks them, producing scar tissue around the device. This buildup of tissue, known as fibrosis, can interfere with the device's function.
* * *
- Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
* * *
When medical devices are implanted in the body, the immune system often attacks them, producing scar tissue around the device. This buildup of tissue, known as fibrosis, can interfere with the device's function.